Yibitan® is the commercial brand name of Edaravone and Sodium Chloride Injection. Yibitan is the Chinese pinyin brand name. It is a free radical scavenger. By eliminating reactive oxygen species, it suppresses oxidative neuronal damage after cerebral infarction. Main IndicationsTreatment…
Xianbixin® is the commercial brand name of Edaravone and Dexborneol Concentrated Solution for Injection. Xianbixin is the Chinese pinyin brand name. It is a compound preparation containing edaravone and dexborneol. Edaravone scavenges free radicals and reduces oxidative stress injury, while…
Awiqli® is the commercial brand name of Insulin Icodec Injection. Changchong is the Chinese pinyin brand name. It is a long-acting basal insulin analogue, which binds to insulin receptors to regulate glucose metabolism and achieve sustained glycemic control. Main IndicationsTreatment…
Inspra® is the commercial brand name of Eplerenone Tablets, a selective aldosterone receptor antagonist. Limeitong is the Chinese pinyin brand name of the domestic generic version of eplerenone. It blocks mineralocorticoid receptors to reduce sodium and water retention and exert…
Aidaluo® is the commercial brand name of Ebdarokimab Injection, a fully human monoclonal antibody developed by Akesobio. It targets the P2X3 receptor to inhibit pain signal transmission in sensory neurons. Main IndicationsFor the treatment of refractory chronic cough in adult…
Yinuoqing® is the commercial brand name of Efsubaglutide alfa Injection, a long‑acting GLP‑1 receptor agonist developed by Innogen. It activates GLP‑1 receptors to slow gastric emptying, suppress appetite and regulate glucose metabolism. Main IndicationsFor the treatment of type 2 diabetes…
Atozet® is the commercial brand name of Ezetimibe and Atorvastatin Calcium Tablets (II), an oral fixed‑combination product developed by Organon. Ezetimibe inhibits intestinal cholesterol absorption, while atorvastatin calcium suppresses hepatic cholesterol synthesis, jointly lowering blood lipid levels. Main IndicationsFor the…
ATECTURA® is the commercial brand name of Indacaterol Acetate and Mometasone Furoate Powder for Inhalation (Ⅱ), a fixed‑dose combination containing long‑acting beta₂ agonist and inhaled corticosteroid developed by Novartis. Indacaterol acetate relaxes bronchial smooth muscle; mometasone furoate provides potent anti‑inflammatory…
Youtidi® is the commercial brand name of Utidelone Injection, a novel epothilone analogue developed by Chengdu Biostar Pharmaceutical. It stabilizes microtubules, blocks cell mitosis and induces tumor cell apoptosis. Main IndicationsFor the treatment of adult patients with locally advanced or…
Anruixi® is the commercial brand name of Zuberitamab Injection, a fully human anti-CD20 monoclonal antibody developed by BioRay Pharmaceutical. It binds to CD20 antigen on B lymphocytes and induces B-cell lysis to exert anti-tumor effects. Main IndicationsFor the treatment of…